跳至主要内容
临床试验/JPRN-UMIN000031708
JPRN-UMIN000031708已完成未知

The efficacy of febuxostat or topiroxostat on nephropathy in type 2 diabetes with hyperuricemia: A randomized clinical trial - The efficacy of febuxostat or topiroxostat on diabitic nephropathy: A randomized clinical trial

Yokohama City University0 个研究点目标入组 120 人开始时间: 2018年3月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients whose baseline eGFR were <30 ml/min/1.73m^2. 2)Patients treated with uric acid synthesis inhibitors or uricosuric drugs. 3)Patients with severe infections. 4)Patients who are receiving chemotherapy with malignancy. 6)Patients who are judged by an investigator to be inappropriate for this study for any other reason.

研究者

相似试验